Opin­ion: Biden needs to step up and nom­i­nate an FDA com­mis­sion­er

5 years ago
FDA+
Opinion

Tu­mor-treat­ing elec­tric fields show ear­ly promise in NSCLC — boost­ing both Novo­cure and its Chi­nese biotech part­ner

5 years ago
R&D

Re­cur­sion lays out $300M+ goal in IPO terms; Evotec and Bris­tol My­ers team up to spin out Ger­man re­search

5 years ago
News Briefing

FDA dis­pens­es with in-per­son re­quire­ment for abor­tion pill ac­cess dur­ing the pan­dem­ic

5 years ago
Pharma
FDA+

Tim Lu’s gene-cir­cuit star Sen­ti signs up for a $645M dis­cov­ery al­liance with Roche sub Spark

5 years ago
Deals

Bain dou­bles down on Tony Coles’ quest to get a late-stage Parkin­son’s drug through to mar­ket

5 years ago
Financing
R&D

Jaguar, Sean Nolan's lat­est biotech, rais­es $139M as they fol­low Taysha's foot­steps

5 years ago
Financing

Neil Ku­mar's Bridge­Bio finds 7 new aca­d­e­m­ic part­ners to join the fight against ge­net­ic dis­ease

5 years ago
Deals

Covid-19 roundup: Cit­ing a lack of need, Gilead cuts remde­sivir study; No­vavax vac­cine pro­duc­tion slowed due to ...

5 years ago
Coronavirus

Toad ven­om to treat de­pres­sion? RA Cap­i­tal wa­gers $125M on lat­est psy­che­del­ic biotech

5 years ago
Financing

Amarin CEO John Thero pass­es ba­ton to Eu­rope com­mer­cial chief as M&A hopes con­tin­ue to de­flate

5 years ago
People

Ar­cel­lx rais­es mega-round to put con­trol­lable CAR-T in­to the clin­ic

5 years ago
Financing
R&D

J&J paus­es vac­cine roll­out as feds probe rare cas­es of blood clots

5 years ago
FDA+
Coronavirus

Or­biMed-backed The­seus de­buts with $100M round in hero­ic quest for 'pan-vari­ant' ki­nase in­hibitors

5 years ago
Financing
R&D

In­vestors throw $189M at Flag­ship star­tup's mis­sion to 'de­code' in­ter­ac­tions be­tween T cells and anti­gens

5 years ago
Financing

The hunt for a hep B cure heats up, as An­tios Ther­a­peu­tics preps for an IPO

5 years ago
Financing

End­points ex­clu­sive: Bob Nelsen's Re­silience snags Flori­da CD­MO work­ing with the De­fense De­part­ment on Covid-19 ...

5 years ago
Deals

Jazz Phar­ma­ceu­ti­cals push­es to ex­pand la­bel on Xy­wav; FDA eyes Oc­to­ber for de­ci­sion on Seagen's lat­est ADC

5 years ago
News Briefing

Pa­trizia Cavaz­zoni named per­ma­nent di­rec­tor of CDER, adding to ques­tions around where Wood­cock will end up

5 years ago
People
FDA+

Covid-19 roundup: As­traZeneca's Farx­i­ga fails PhI­II test; Sup­ply deal for Eli Lil­ly's so­lo bam­lanivimab of­fi­cial­ly ...

5 years ago
Coronavirus

Gene ther­a­pies for neu­rode­gen­er­a­tive dis­eases: Pfiz­er, No­var­tis, Bio­gen and oth­ers seek more from FDA

5 years ago
Cell/Gene Tx
FDA+

Sage touts first win in $3B Bio­gen pact, but safe­ty pro­file, doubts over da­ta cloud road ahead

5 years ago
R&D

IPO mar­ket con­tin­ues to churn with a pair of Covid-19 biotechs seek­ing Nas­daq, while mi­to­chon­dria-fo­cused Re­neo ...

5 years ago
Financing
Coronavirus

Sanofi teams with vir­tu­al re­al­i­ty biotech on oral Dupix­ent suc­ces­sor

5 years ago
Deals
Discovery
First page Previous page 718719720721722723724 Next page Last page
A service from the Financial Times